arrow
S

Stergios Boussios

medway nhs foundation trust
H指数:48
被引数:5,673

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trials

选择性雌激素受体降解剂在绝经前乳腺癌中的应用:机会窗口试验中的生物学活性与终点相关性

2026-09-130
PRE
Eprenetapopt in combination with carboplatin in high-grade ovarian and triple negative breast cancer cell lines with acquired resistance to olaparib

Eprenetapopt 与 carboplatin 联合应用于对 olaparib 获得性耐药的高级别卵巢癌和三阴性乳腺癌细胞系

2026-04-030
OAAI
Efficacy of ketogenic metabolic therapy as an adjuvant to the current standard of care in the treatment of glioblastoma: A systematic review of clinical trials

生酮代谢疗法作为当前标准治疗方案在胶质母细胞瘤治疗中的辅助疗效:一项临床试验的系统综述

2025-12-110
OAAI
Unlocking Precision: Bispecific T Cell Engagers and the Next Frontier in Uro-Oncology

解锁精准性:双特异性T细胞结合剂与泌尿肿瘤学的前沿领域

2025-11-200
PRE